Page 146 - Strategies for non-invasive managementof high-grade cervical intraepithelial neoplasia - prognostic biomarkers and immunotherapy Margot Maria Koeneman
P. 146

Chapter 7
Supplemental digital content 2. Questionnaire
 1. What is your professional function?
· Gynecologic oncologist or fellow gynecologic oncology
· Gynecologist with semi-specialization in gynecologic oncology · Gynecologist with other (semi-) specialization
2. In what hospital type are you currently employed?
· University hospital or specialized oncological center · Semi-specialized teaching hospitals
· Non-teaching hospital
3. How many colposcopies do you conduct or supervise yearly? · Less than 30
· 30-100
· More than 100
4. Which method do you usually apply for suspected high-grade dysplasia during colposcopy?
· See-and-treat, regardless of age or future pregnancy wish
· See-and-treat in older patients without future pregnancy wish and diagnostic biopsies in
younger patients with potential pregnancy wish
· Diagnostic biopsies, regardless of age or future pregnancy wish · Other: ...
5. How large do you consider the additional risk of future premature birth following LLETZ, compared to the general population?
· Not increased or marginally increased
· Increased with a factor: ... (whole number)
6. Do you discuss the additional risk of premature birth in pregnancies following LLETZ, with patients who have an indication for LLETZ?
· Yes · No
· Other: ...
7. Are you aware of the application of imiquimod (Aldara   ) for genital warts, in literature or clinical practice? Have you ever applied imiquimod for this indication?
· I am aware of this, I have not applied it myself. · I am aware of this, I have applied it myself.
· I am not aware of this.
8. Are you aware of the application of imiquimod (Aldara ) for vulvar intraepithelial neoplasia (VIN), in literature or clinical practice? Have you ever applied imiquimod for this indication?
· I am aware of this, I have not applied it myself. · I am aware of this, I have applied it myself.
· I am not aware of this.
 144






































































   144   145   146   147   148